Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| cardiac muscle cell | 5 studies | 41% ± 8% | |
| epithelial cell | 4 studies | 37% ± 14% | |
| ciliated cell | 4 studies | 28% ± 8% | |
| type II pneumocyte | 4 studies | 23% ± 3% | |
| glutamatergic neuron | 3 studies | 42% ± 13% | |
| club cell | 3 studies | 24% ± 8% | |
| respiratory goblet cell | 3 studies | 32% ± 12% | |
| type I pneumocyte | 3 studies | 18% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| heart | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 84% | 1531.92 | 484 / 578 | 91% | 32.52 | 1051 / 1155 |
| stomach | 79% | 11071.12 | 284 / 359 | 93% | 30.51 | 266 / 286 |
| uterus | 71% | 1374.86 | 121 / 170 | 80% | 21.47 | 367 / 459 |
| thymus | 63% | 559.17 | 409 / 653 | 83% | 15.53 | 502 / 605 |
| pancreas | 49% | 448.87 | 161 / 328 | 95% | 40.50 | 169 / 178 |
| prostate | 84% | 1128.62 | 205 / 245 | 59% | 5.22 | 298 / 502 |
| intestine | 45% | 2160.70 | 433 / 966 | 97% | 32.78 | 511 / 527 |
| adrenal gland | 100% | 2868.14 | 257 / 258 | 40% | 5.92 | 92 / 230 |
| skin | 72% | 4221.34 | 1305 / 1809 | 64% | 12.40 | 302 / 472 |
| esophagus | 40% | 1038.59 | 575 / 1445 | 96% | 40.48 | 175 / 183 |
| kidney | 97% | 1785.49 | 86 / 89 | 17% | 4.97 | 157 / 901 |
| heart | 95% | 3654.52 | 821 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 95% | 1974.40 | 1267 / 1335 | 0% | 0 | 0 / 0 |
| breast | 19% | 167.34 | 86 / 459 | 72% | 16.34 | 803 / 1118 |
| bladder | 29% | 419.19 | 6 / 21 | 59% | 14.11 | 297 / 504 |
| tonsil | 0% | 0 | 0 / 0 | 73% | 15.64 | 33 / 45 |
| ovary | 3% | 25.81 | 5 / 180 | 61% | 9.16 | 262 / 430 |
| eye | 0% | 0 | 0 / 0 | 43% | 3.93 | 34 / 80 |
| brain | 33% | 328.59 | 862 / 2642 | 6% | 0.63 | 43 / 705 |
| lymph node | 0% | 0 | 0 / 0 | 24% | 1.93 | 7 / 29 |
| muscle | 16% | 154.21 | 131 / 803 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 11% | 2.31 | 43 / 406 |
| peripheral blood | 6% | 41.50 | 55 / 929 | 0% | 0 | 0 / 0 |
| spleen | 5% | 28.34 | 11 / 241 | 0% | 0 | 0 / 0 |
| adipose | 2% | 28.20 | 23 / 1204 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0032580 | Cellular component | Golgi cisterna membrane |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0008376 | Molecular function | acetylgalactosaminyltransferase activity |
| GO_0033842 | Molecular function | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity |
| Gene name | B4GALNT3 |
| Protein name | Beta-1,4-N-acetyl-galactosaminyltransferase 3 Beta-1,4-N-acetylgalactosaminyltransferase 3 (B4GalNAcT3) (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2) |
| Synonyms | |
| Description | FUNCTION: Transfers N-acetylgalactosamine (GalNAc) from UDP-GalNAc to N-acetylglucosamine-beta-benzyl with a beta-1,4-linkage to form N,N'-diacetyllactosediamine, GalNAc-beta-1,4-GlcNAc structures in N-linked glycans and probably O-linked glycans. Mediates the N,N'-diacetyllactosediamine formation on gastric mucosa. . |
| Accessions | E9PHD9 Q6L9W6 ENST00000266383.10 ENST00000322843.3 |
